It was reported that long-term overexposure to CDK9 may result in pathological cardiac hypertrophy; thus, CDK9 inhibitors have been investigated as new targets for treating hypertrophic cardiomyopathy (10). The gene discussed is CDK9; the disease is hypertrophic cardiomyopathy.